메뉴 건너뛰기




Volumn 28, Issue 1, 2010, Pages 111-112

Bevacizumab may be active in myelofibrosis

Author keywords

Bevacizumab; Myelofibrosis; Myeloproliferative disorders

Indexed keywords

BEVACIZUMAB; HYDROXYUREA;

EID: 72449212253     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900902918502     Document Type: Article
Times cited : (2)

References (5)
  • 1
    • 0033898269 scopus 로고    scopus 로고
    • Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity
    • Lundberg, L.G.; Lerner, R.; Sundelin, P.; Rogers, R.; Folkman, J.; Palmbad, J. Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity. Am J Pathol 2000, 157(1), 15-19.
    • (2000) Am J Pathol , vol.157 , Issue.1 , pp. 15-19
    • Lundberg, L.G.1    Lerner, R.2    Sundelin, P.3    Rogers, R.4    Folkman, J.5    Palmbad, J.6
  • 2
    • 34250190263 scopus 로고    scopus 로고
    • Increased angiogenesis in chronic idiopathic myelofibrosis: Vascular endothelial growth factor as a prominent angiogenic factor
    • Steurer, M.; Zoller, H.; Augustin, F.; Fong, D.; Heiss, S.; Strasser- Weippl, K.; Gastl, G.; Tzankov, A. Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor. Hum Pathol 2007, 38(7), 1057-1064.
    • (2007) Hum Pathol , vol.38 , Issue.7 , pp. 1057-1064
    • Steurer, M.1    Zoller, H.2    Augustin, F.3    Fong, D.4    Heiss, S.5    Strasser-Weippl, K.6    Gastl, G.7    Tzankov, A.8
  • 3
    • 33746702623 scopus 로고    scopus 로고
    • Quantitative evaluation of bone marrow angiogenesis in idiopathicmyelofibrosis
    • Ni, H.; Barosi, G.; Hoffman, R. Quantitative evaluation of bone marrow angiogenesis in idiopathicmyelofibrosis. Am J Clin Pathol 2006, 126(2), 241-247.
    • (2006) Am J Clin Pathol , vol.126 , Issue.2 , pp. 241-247
    • Ni, H.1    Barosi, G.2    Hoffman, R.3
  • 5
    • 38849089244 scopus 로고    scopus 로고
    • Complete response of relapsed angioimmunoblastic T-cell lymphoma following therapy with bevacizumab. Letter to the editor
    • Aguiar Bujanda, D. Complete response of relapsed angioimmunoblastic T-cell lymphoma following therapy with bevacizumab. Letter to the editor. Ann Oncol 2008, 19(2), 396-397.
    • (2008) Ann Oncol , vol.19 , Issue.2 , pp. 396-397
    • Aguiar Bujanda, D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.